trihexyphenidyl has been researched along with Adenohypophyseal Hyposecretion in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pharmacological treatment with tetrabenazine, clonazepam and trihexiphenydile allowed a very limited improvement of dystonia; the course was complicated by dystonic storms and decompensations resulting from the iatrogenous panhypopituitarism." | 3.74 | [Severe generalized dystonia due to postradiotherapy cerebral calcifications]. ( Anheim, M; Chanson, JB; Fleury, M; Lagha-Boukbiza, O; Sellal, F; Tranchant, C, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chanson, JB | 1 |
| Anheim, M | 1 |
| Lagha-Boukbiza, O | 1 |
| Fleury, M | 1 |
| Sellal, F | 1 |
| Tranchant, C | 1 |
1 other study available for trihexyphenidyl and Adenohypophyseal Hyposecretion
| Article | Year |
|---|---|
[Severe generalized dystonia due to postradiotherapy cerebral calcifications].
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Brain Neoplasms; Calcinosis; Child; Clonazepam; Craniopharyng | 2008 |